Comment on CMS Guidance regarding the Medicare Prescription Drug Inflation Rebate Programme Due March 11, 2023
The Wait is over. . . Or is it? Proposed Rules for Telemedicine Prescribing by the DEA: Initial Impressions and Key Takeaways
No more surprise medical bills: Providers continue to challenge government rulemaking under the No Surprises Act
